InsidersTradesSigma
큐리언트 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 큐리언트 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 큐리언트 has logged 101 public disclosures. Market capitalisation: €946.5bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is openly available.
101
Insider Decl.
0
Thresholds
€42,602
27 ops.
Buy Volume
·
2 ops.
Sell Volume
16Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,908 of 26,293 companies
16.1
score / 100
Value23
Quality9
FCF yld-4.5%
Earn yld-4.2%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 April 2026
Declarations101 total
80,000 sharesKRXDART:20260303002340
1,487,693 sharesKRXDART:20241129000711
Ideal exit: 19 Aug 2025 (T+270)
1,661,065 sharesKRXDART:20241029000023
Ideal exit: 22 Jul 2025 (T+270)
1,661,065 sharesKRXDART:20241028000395
Ideal exit: 22 Jul 2025 (T+270)
5,037,281 sharesKRXDART:20240805000130
Ideal exit: 26 Apr 2025 (T+270)
25 of 101 declarations